械三证的含金量还在上升国家药品监督管理局药品审评中心信息显示:由巨子生物申报的“重组胶原蛋白冻干纤维”产品,已于6月13日获得受理,药品类型为化药,申请类型为药械组合。图源:国家药品监督管理局药品审评中心巨子生物2022年发布的招股书内容显示,医美领域正在开发的三类医疗器械证有以下4款产品:不难发现,本次获得受理的重组胶原蛋白冻干纤维正是重组胶原蛋白固体制剂,适应症为:用于抗衰老的皮内及皮下肌肤...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.